“…For bone-filling purposes, CaPs have been utilized as bioactive components of solid ceramic, coatings, self-setting CaP cements (CPC), as well as advanced polymers, intending to function as a scaffold for bone formation ( Parent et al, 2017 ). The family of CaP biomaterials comprises varying phase compositions, including HA [Ca 10 (PO 4 ) 6 (OH) 2 ], tricalcium phosphate [TCP, Ca 3 (PO 4 ) 2 ], octacalcium phosphate [OCP, Ca 8 (HPO 4 ) 2 (PO 4 ) 4 ·5H 2 O], dicalcium phosphate dihydrate [DCPD, CaHPO 4 .2H 2 O], and amorphous calcium phosphate [ACP, CaxHy(PO 4 )z·nH 2 O, n = 3–4.5; 15–20% H 2 O], can be used in a variety of applications due to differences in solubility, stability, and mechanical strength ( Jeong et al, 2019 ; Dorozhkin, 2021 ). CaP-based biomaterials provide a strong biomaterial/bone interface and demonstrate promising biological properties such as biodegradability, osteoconductivity, and in some cases even osteoinductivity (i.e., the ability of the material to induce de novo bone formation without the presence of osteogenic factors) ( LeGeros, 2008 ; Chai et al, 2012 ; Stastny et al, 2019 ).…”